MEDICA 2025 successfully concluded in Düsseldorf, Germany. This year’s exhibition, themed “Meet Health. Future. People.”, brought together global leaders and innovations in the medical industry. As a rising force in the field of minimally invasive surgical instruments, SurgSci made its fourth appearance at MEDICA, presenting a comprehensive portfolio of innovative products and solutions on the international stage.
Exhibition Highlights
Throughout the exhibition, the SurgSci booth attracted a steady stream of visitors, including experts and partners from Europe, Asia, and the Americas. Attendees showed strong interest in experiencing the products firsthand, creating a lively atmosphere that underscored the global attention on SurgSci’s innovative achievements.
At MEDICA 2025, SurgSci showcased a complete product portfolio:
Surgical Energy Platform
Urological Surgical Product
Minimally Invasive Surgical Consumables
Several innovative products became focal points of the booth. With precise performance and proven clinical value, they drew significant interest from customers, and many partners expressed intentions for future collaboration. Through live demonstrations and detailed presentations, SurgSci highlighted the practical applications and benefits of its solutions. Scholars, industry representatives, and partners from around the world engaged actively, raising professional questions and sharing practical needs, to which the SurgSci team responded attentively in a professional and dynamic environment.
Exhibition Achievements
This participation not only demonstrated SurgSci’s product strength but also yielded substantial outcomes. The company established initial cooperation agreements with multiple international partners, laying the foundation for further expansion into overseas markets. Its innovative products received high praise on-site, significantly enhancing brand visibility on the global stage. At the same time, in-depth discussions with long-term partners strengthened existing relationships and provided valuable feedback to guide future product optimization and R&D. Over the course of four days, the exhibition showcased SurgSci’s technological capabilities and innovation, while opening new chapters in its global development journey.
A Perfect Conclusion
With the successful conclusion of MEDICA 2025, SurgSci once again earned recognition from the international market through its commitment to innovation and quality. Looking ahead, the company will continue to focus on minimally invasive surgery, guided by clinical needs, empowering physicians, and benefiting patients. SurgSci remains dedicated to delivering more efficient, precise, and safe medical solutions, contributing to the advancement of global healthcare.
SurgSci – MEDICA 2025 Concludes with Success!
